Omeros Corporation
ANTIBODIES SPECIFICALLY BINDING TO MASP-3 FOR THE TREATMENT OF VARIOUS DISEASES AND DISORDERS
Last updated:
Abstract:
The present invention relates to MASP-3 inhibitory antibodies and compositions comprising such antibodies for use in inhibiting the adverse effects of MASP-3 dependent complement activation.
Status:
Application
Type:
Utility
Filling date:
23 Jun 2020
Issue date:
8 Oct 2020